Insulatard nph human side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Insulatard nph human. Common side effects include device failure among females, and ascites among males.
The phase IV clinical study is created by eHealthMe based on 641 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
641 people who take Insulatard Nph Human and have side effects are studied.
What is Insulatard Nph Human?
Insulatard nph human has active ingredients of insulin susp isophane semisynthetic purified human. Currently, eHealthMe is studying from 650 Insulatard nph human users.
Number of Insulatard nph human reports submitted per year:
Insulatard nph human side effects by time on the drug *:
Insulatard nph human side effects by gender *:
Insulatard nph human side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Insulatard nph human?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on insulin susp isophane semisynthetic purified human (the active ingredients of Insulatard nph human) and Insulatard nph human (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Insulatard nph human:
- Insulatard nph human (650 reports)
All Insulatard nph human side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Periostat and Avastin drug interaction - 6 seconds ago
- Diovan and Postmenopausal Haemorrhage - a minute ago
- Invanz and Dimethyl Sulfoxide drug interaction - 2 minutes ago
- Enhertu and Pancytopenia Aggravated - 2 minutes ago
- Zofran and Metoclopramide Hydrochloride drug interaction - 2 minutes ago
- Haldol and Oxcarbazepine drug interaction - 3 minutes ago
- Toradol and Hydroxyzine Hydrochloride drug interaction - 3 minutes ago
- Glimepiride and Temozolomide drug interaction - 3 minutes ago
- Alogliptin and Neosar drug interaction - 4 minutes ago
- Ezetimibe and Rythmol drug interaction - 4 minutes ago